From a total of 50 healthy male Filipino subjects enrolled in the study, 34 completed a 10-month open-label evaluation of 2% topical minoxidil. The remaining 16 withdrew because of disinterest or noncompliance with the regular monthly follow-ups. Both objective measurement of hair growth by counting of indeterminate and terminal hairs in the target balding area and subjective evaluation by subjects and investigators were made, and photographs taken to document the efficacy of new hair growth.52% of subjects noted minimal new hair growth, while 42% noted moderate new hair growth. In comparison, the investigators rated 79% of subjects as having minimal new hair growth and 21% as having moderate new hair growth. Overall, 70.5% of subjects noted decreased shedding at the end of treatment. Furthermore, terminal hair counts at the end of treatment showed statistically significant (paired t-test) growth. No significant physical findings or laboratory abnormalities were seen.